Entwodiksyon ak aplikasyon CAS:1098-97-1|PIRITIOXIN
Itilize kòm entèmedyè pharmaceutique
Spesifikasyon CAS:1098-97-1|PIRITIOXIN
| Atik | Spesifikasyon |
Pwen k ap fonn: 218-220 degre
Pwen bouyi: 742.8±6 0.0 degre (Prevwa)
Dansite: 1.448±0.06g/cm3 (Prevwa)
Kondisyon depo: Keepindarkplace, Inertatmosphere, Tanperati chanm
Solibilite: Fonn nan dimethyl sulfoxide
Koyefisyan asidite (pKa): 9.31± 0.10 (Predi)
Koulè: blan a jòn limyè ak zoranj limyè
Pake ak transpò CAS:1098-97-1|PIRITIOXIN
Pake: 1g, 25g, 100g, 1kg, 25kg, 100kg;
Transpò: pa courrier / pa lè / pa lanmè.
Atik ki gen rapò ak CAS:1098-97-1|PIRITIOXIN
Der Einfluß von Pyrithioxin auf die Blut-Hirnschranke
G Quadbeck, HR Landmann, W Sachsse, I Schmidt - Farmakoloji, 1972 - karger.com
Ogmantasyon nan konsantrasyon asetilkolin nan sèvo a nan 'old'rat apre tretman ak pyrithioxin (Encephabol).
KJ Martin, S Vyas - jounal Britanik famasi, 1987 - ncbi.nlm.nih.gov
Baj popilè: cas:1098-97-1|pyrithioxin, Lachin cas:1098-97-1|pyrithioxin manifaktirè, faktori






![CAS:1160293-27-5 |1,3-DiMethyl2-[4-(Methoxycarbonyl)-2-nitrofenil]propandioat](/uploads/202340266/small/cas-1160293-27-5-4b1d6c56-f119-493b-a73e-9955cfc1e45b.png?size=195x0)


![Nimewo CAS 536759-91-8|Etil 1-(4-metoksifenil)-6-({4-nitrofenil)-7-oxo-4,5-dihydropyrazolo[3,{{ 9}}c]piridin-3-karboxylate](/uploads/202340266/small/cas-no-536759-91-8-ethyl-1-4-methoxyphenyl-6ece76d40-2cc1-473e-af48-ea1d51af85cd.jpg?size=195x0)

![CAS:303976-65-0| 1,1'-Bifenil, 4-[difluoro(3,4,5-trifluorofenoksi)metil]-3,5-difluoro-4'-(trans{{ {12}}pentylcyclohexyl)-](/uploads/202340266/small/cas-303976-65-0-1-1-biphenyl-4-difluoro-3-4-56cf7b6f5-7cd0-4d20-9c38-5b4784413ea3.jpg?size=195x0)